Abstract
Against sulbenicillin- and gentamicin-susceptible strains of Pseudomonas aeruginosa, SCE-129 was about 10 times more active than sulbenicillin and had a similar activity to gentamicin and dibekacin. Sulbenicillin-resistant strains of P. aeruginosa were moderately resistant to SCE-129, whether these strains were gentamicin-resistant or not. Gentamicin-resistant strains of P. aeruginosa were resistant to dibekacin but not to SCE-129. Against P. maltophilia, the minimum inhibitory concentration of SCE-129 resembled those of sulbenicillin, gentamicin, and dibekacin. Most strains of P. cepacia were moderately resistant to SCE-129 and sulbenicillin and highly resistant to gentamicin and dibekacin.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Akiyoshi M., Sato K., Nakada H., Tajima T. [Audiometric and histopathologic evaluation of ototoxicity of 3',4'-dideoxykanamycin B, a new aminoglycoside antibiotic (author's transl)]. Jpn J Antibiot. 1974 Feb;27(1):15–26. [PubMed] [Google Scholar]
- Darrell J. H., Waterworth P. M. Carbenicillin resistance in Pseudomonas aeruginosa from clinical material. Br Med J. 1969 Jul 19;3(5663):141–143. doi: 10.1136/bmj.3.5663.141. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Duncan I. B. Susceptibility of 1,500 isolates of Pseudomonas aeruginosa to gentamicin, carbenicillin, colistin, and polymyxin B. Antimicrob Agents Chemother. 1974 Jan;5(1):9–15. doi: 10.1128/aac.5.1.9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Falco F. G., Smith H. M., Arcieri G. M. Nephrotoxicity of aminoglycosides and gentamicin. J Infect Dis. 1969 Apr-May;119(4):406–409. doi: 10.1093/infdis/119.4-5.406. [DOI] [PubMed] [Google Scholar]
- Gaman W., Cates C., Snelling C. F., Lank B., Ronald A. R. Emergence of gentamicin- and carbenicillin-resistant Pseudomonas aeruginosa in a hospital environment. Antimicrob Agents Chemother. 1976 Mar;9(3):474–480. doi: 10.1128/aac.9.3.474. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hawkins J. E., Jr, Johnsson L. G., Aran J. M. Comparative tests of gentamicin ototoxicity. J Infect Dis. 1969 Apr-May;119(4):417–431. doi: 10.1093/infdis/119.4-5.417. [DOI] [PubMed] [Google Scholar]
- Kosek J. C., Mazze R. I., Cousins M. J. Nephrotoxicity of gentamicin. Lab Invest. 1974 Jan;30(1):48–57. [PubMed] [Google Scholar]
- Moody M. R., Young V. M., Kenton D. M. In vitro antibiotic susceptibility of pseudomonads other than Pseudomonas aeruginosa recovered from cancer patients. Antimicrob Agents Chemother. 1972 Nov;2(5):344–349. doi: 10.1128/aac.2.5.344. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Nakazawa T., Fukushima K. [Effect of a new antibiotic 3',4'-dideoxykanamycin B on auditory function of the guinea pig]. Jpn J Antibiot. 1973 Feb;26(1):24–27. [PubMed] [Google Scholar]
- Nord C. E., Wadström T., Wretlind B. Synergistic effect of combinations of sulfamethoxazole, trimethoprim, and colistin against Pseudomonas maltophilia and Pseudomonas cepacia. Antimicrob Agents Chemother. 1974 Oct;6(4):521–523. doi: 10.1128/aac.6.4.521. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Tsuchiya K., Kondo M., Nagatomo H. SCE-129, antipseudomonal cephalosporin: in vitro and in vivo antibacterial activities. Antimicrob Agents Chemother. 1978 Feb;13(2):137–145. doi: 10.1128/aac.13.2.137. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wersäll J., Lundquist P. G., Björkroth B. Ototoxicity of gentamicin. J Infect Dis. 1969 Apr-May;119(4):410–416. doi: 10.1093/infdis/119.4-5.410. [DOI] [PubMed] [Google Scholar]